FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. [electronic resource]
- PloS one 2014
- e89388 p. digital
Publication Type: Journal Article
1932-6203
10.1371/journal.pone.0089388 doi
Cell Cycle Proteins--genetics DNA Mutational Analysis F-Box Proteins--genetics F-Box-WD Repeat-Containing Protein 7 Humans Mutation--genetics Neoplasms--genetics Phenotype TOR Serine-Threonine Kinases--antagonists & inhibitors Texas Ubiquitin-Protein Ligases--genetics